Cell Wall Composition and Decreased Autolytic Activity and Lysostaphin Susceptibility of Glycopeptide-Intermediate Staphylococcus aureus
Open Access
- 1 October 2004
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 48 (10) , 3749-3757
- https://doi.org/10.1128/aac.48.10.3749-3757.2004
Abstract
The cell wall composition and autolytic properties of passage-selected glycopeptide-intermediate Staphylococcus aureus (GISA) isolates and their parent strains were studied in order to investigate the mechanism of decreased vancomycin susceptibility. GISA had relatively modest changes in peptidoglycan composition involving peptidoglycan interpeptide bridges and somewhat decreased cross-linking compared to that of parent strains. The cell wall phosphorus content of GISA strains was lower than that of susceptible parent strains, indicating somewhat lower wall teichoic acid levels in the GISA strains. Similar to whole cells, isolated crude cell walls retaining autolytic activity of GISA had drastically reduced autolytic activity compared to that of parent strains, and this arose early in the development of the GISA phenotype. This was due to an alteration in the autolytic enzymes of GISA as revealed by normal susceptibility of GISA-purified cell walls to parental strain autolysin extract and lower activity and altered peptidoglycan hydrolase activity profiles in GISA autolysin extracts compared to those of parent strains. Northern blot analysis indicated that expression of atl , the major autolysin gene, was significantly downregulated in a GISA strain compared to that of its parent strain. In contrast to whole cells, which showed decreased lysostaphin susceptibility, purified cell walls of GISA showed increased susceptibility to lysostaphin. We suggest that in our GISA strains, decreased autolytic activity is involved in the tolerance of vancomycin and the activities of endogenous autolysins are important in conferring sensitivity to lysostaphin on whole cells.Keywords
This publication has 60 references indexed in Scilit:
- Intact mutS in Laboratory-Derived and Clinical Glycopeptide-Intermediate Staphylococcus aureus StrainsAntimicrobial Agents and Chemotherapy, 2004
- Microarray Transcription Analysis of Clinical Staphylococcus aureus Isolates Resistant to VancomycinJournal of Bacteriology, 2003
- Alterations in phage-typing patterns in vancomycin-intermediate Staphylococcus aureusJournal of Medical Microbiology, 2003
- Are the molecular strategies that control apoptosis conserved in bacteria?Trends in Microbiology, 2003
- Description of Staphylococcus Serine Protease ( ssp ) Operon in Staphylococcus aureus and Nonpolar Inactivation of sspA -Encoded Serine ProteaseInfection and Immunity, 2001
- The d -Alanine Residues of Staphylococcus aureus Teichoic Acids Alter the Susceptibility to Vancomycin and the Activity of Autolytic EnzymesAntimicrobial Agents and Chemotherapy, 2000
- Identification and molecular characterization of a gene homologous to epr (endopeptidase resistance gene) in Staphylococcus aureusGene, 1998
- Conditions that induce Staphylococcus aureus heat shock proteins also inhibit autolysisFEMS Microbiology Letters, 1998
- The Staphylococcus aureus scdA gene: a novel locus that affects cell division and morphogenesisMicrobiology, 1997
- Lif, the lysostaphin immunity factor, complements FemB in staphylococcal peptidoglycan interpeptide bridge formationFEMS Microbiology Letters, 1997